RO 23-6152
Code | Size | Price |
---|
TAR-T28571-5mg | 5mg | £1,091.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28571-50mg | 50mg | £2,143.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28571-100mg | 100mg | £2,801.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
RO 23-6152, a new calcium antagonist, can inhibit platelet aggregation in vitro associated with occlusive coronary thrombus formation.
CAS:
108383-96-6
Formula:
C26H29ClN2O4S
Molecular Weight:
501.04
Purity:
0.98
SMILES:
Cl.COc1ccc(cc1)[C@@H]1Sc2c(ccc3ccccc23)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
References
1. Sordahl LA, Rex KA, Benedict CR. In vivo inhibition of platelet aggregation and occlusive coronary thrombus formation by a new calcium antagonist (R023-6152). J Cardiovasc Pharmacol. 1991 Oct;18(4):504-10. PubMed PMID: 1724526.
2. Medh JD, Rex KA, Benedict CR, Sordahl LA. In vitro and in vivo effects of R023-6152 on heart mitochondrial calcium and energy metabolism. J Cardiovasc Pharmacol. 1991 Oct;18(4):473-7. PubMed PMID: 1724522.
3. Folkers HB, van Zwienen JC, Boer P, Kleinbloesem CH, Geyskes GG. Hemodynamic effects of Ro 23-6152 in patients with essential hypertension. Eur J Clin Pharmacol. 1991;41(4):307-11. PubMed PMID: 1804644.